The biggest stories of the day delivered to your inbox.

The company's new flagship phone has the overall nicest display I've seen on a smartphone. The Vivo Nex 3, which I've been playing with for about 10 days, has an enormous, 6.89-inch Super AMOLED ...

designation to its investigational in vivo genome-editing candidate, Nexiguran ziclumeran (nex-z, also known as NTLA-2001), for a new indication. The regulatory body has now granted the RMAT ...

Android OEMs like Oppo, with their Find X, and Vivo, with the Nex series, led the charge and showcased devices with seamless, all-screen fronts. Huawei, Xiaomi, Realme, OnePlus, Asus, and Samsung ...

Intellia Therapeutics, Inc. NTLA is developing its lead CRISPR-based, in vivo genome-editing candidate, nexiguran ziclumeran (nex-z, formerly known as NTLA-2001) for the treatment of transthyretin ...